Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Magnetic Compression Anastomosis in Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes (MAGvMED Study)

NCT07317115 is registered in ClinicalTrials.gov with GT Metabolic Solutions, Inc. as lead sponsor.

NCT NCT07317115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07317115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Magnetic Compression Anastomosis in Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes (MAGvMED Study)
Lead sponsor
GT Metabolic Solutions, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
March 18, 2026
Completion date
June 30, 2028
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity & overweight, obesity (disorder), type 2 diabetes (t2dm)